By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Elan Pharmaceuticals 

7475 Lusk Boulevard

San Diego  California  92121  U.S.A.
Phone: n/a Fax:


Drug Delivery



Company News
Elan Pharmaceuticals (ELN) Lab Liquidation Auctions -- South San Francisco Closure; to be Hosted by BioSurplus on Its Secure Online Auction Platform 1/9/2013 9:42:25 AM
Elan Pharmaceuticals (ELN) Announces Webcast of Fourth Quarter and Full-Year 2011 Financial Results 1/26/2012 6:47:25 AM
Elan Pharmaceuticals (ELN) Pays Transition Therapeutics Inc. (TTH.TO) $9M in Amended Deal for Phase II Alzheimer Candidate; Transition Eligible for $11 Million More 12/27/2010 7:40:40 AM
Infosys Technologies and Elan Pharmaceuticals (ELN) Apply Co-creation Model to Transform Discovery Research 2/2/2010 9:27:18 AM
Elan Pharmaceuticals (ELN) Reports Fourth Quarter and Full-Year 2007 Financial Results 2/13/2008 8:58:29 AM
Elan Pharmaceuticals (ELN) Selects Medidata Solutions, Inc. Rave(R) to Support Clinical Development Activities 12/17/2007 9:09:34 AM
Elan Pharmaceuticals (ELN) Joins GeneGo, Inc.'s MetaTox Consortium 11/27/2007 9:21:22 AM
Elan Pharmaceuticals (ELN) Licenses Software and Databases From GeneGo, Inc. 10/30/2007 7:59:31 AM
Tripos Discovery Research Ltd. (TRPS), a Subsidiary of Commonwealth Biotechnologies, Inc. (CBTE), Signs Library Analysis Agreement with Elan Pharmaceuticals (ELN) 8/9/2007 12:24:11 PM
Alzheimer's Drug Discovery Foundation and Elan Pharmaceuticals (ELN) Announce Winners of Second Annual Novel Discovery Award Program 3/1/2007 12:45:53 PM